How stock buybacks have become Wall Street’s new drug

By WALLACE WITKOWSKI at Marketwatch With the Federal Reserve’s quantitative-easing program out of the picture, share buybacks are now the preferred way to boost stock prices in the face of softening earnings. But like QE, it is unclear how long the buyback boom can last. In the first quarter of 2015, companies in the S&P […]
You must be a Stockman's Corner member in order to view this post, subscribe to Monthly Subscription, Quarterly Subscription or Annual Subscription.